Healthcare industry

Press release - 07/04/2009

What drove the cow mad? New insights into prion diseases

For over twenty years scientists have known that a normal protein in the brain can become harmful and cause deadly illnesses such as Creutzfeld-Jakob disease CJD in humans and bovine spongiform encephalopathy BSE in cattle. What researchers have not been able to explain was why this natural prion protein PrP is produced by our bodies in the first place. A team of researchers at the University Constance have now shown that PrP plays a beneficial…

The European eLearning Award honours outstanding examples of teaching and learning using digital media. This year the INMEDEA Simulator online learning system from Tübingen-based INMEDEA GmbH came second in the categories of media didactics and overall impression.

Press release - 19/11/2009

TET Systems and Novo Nordisk sign license agreement

TET Systems Holding GmbH & Co. KG (“TET Systems”), a worldwide leader in controlled gene expression, today announced that TET Systems and Novo Nordisk A/S have signed a license agreement allowing the Hagedorn Research Institute (HRI), a research institute within Novo Nordisk A/S, the use of the Tet Technology for its internal research activities.

Graduates from the private training college of the Deutsches Erwachsenen-Bildungswerk (German Adult Education Centre) in Fellbach received their certifi-cates last Friday from principal Claudia Volz. The newly qualified assistants in chemical and pharmaceutical engineering were joined by twelve biotechnology assistants (BioTA). The year's top BioTA-graduate, Juliane Maget, received a Euro 250 award from BioRegio STERN Management GmbH.

Most people are well aware that sunbathing can have dangerous consequences. In Switzerland the debate concerning the undesirable side effects of sunscreens has been temporarily put on hold but will most likely start up again with the onset of the winter season. Daniel R. Dietrich chair of the Department of Toxicology at the University of Constance gives us more details in the following interview.

Press release - 12/11/2012

Spot the difference: The 1000 Genomes Project

The 1000 Genomes Project presents a map of normal human genetic variation – everything from tiny changes in the genetic code to major alterations in our chromosomes. In a DNA version of ‘spot-the-difference’, EMBL scientists and their colleagues studied the genomes of 1092 healthy people from Europe, the Americas and East Asia, systematically tracking what makes us different from each other. Their results, published in Nature, open new approaches…

Press release - 03/11/2015

CureVac raises $110 Million in a private placement

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline. CureVac also announces the change of its corporate legal form to a joint stock company, Aktiengesellschaft (AG).

Eggenstein-Leopoldshafen – 14 December 2016: amcure, a biopharmaceutical company developing first-in-class cancer therapeutics, today announced the closing of a Series B financing round amounting to a total of EUR 6 million.

Acousia Therapeutics GmbH announced today the closing of a new investment round of EUR 2.5 million to finance research programs directed at the development of small molecules to treat sensorineural hearing loss and protecting sensory hair cells of the inner ear to prevent hearing loss in at-risk patients.

GATC, one of the leading sequencing provider will be a part of the Eurofins Group as of July 2017 to create the leading company in the worldwide sequencing market.

Press release - 05/09/2017

Cell marking opens up a window into the body

A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer's and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life…

Press release - 03/04/2018

Double success for Heidelberg stem cell researchers

Two awards at once, both carrying high monetary prizes, go to young researchers from the Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ): Simon Raffel will receive the 2018 Walter Schulz Prize. Simon Haas will share the 2018 Otto Schmeil Prize with his colleague Lars Velten from EMBL.

University takes next hurdle in the German government’s Excellence Strategy funding program. The University of Tübingen is to have three new Clusters of Excellence.As part of the German government’s Excellence Strategy funding forhigher education research, Tübingen will host new outstanding research networks starting in January 2019. Representatives of Germany’s higher education policymakers announced the decision in Bonn on Thursday.

Two Clusters of Excellence for the University of Freiburg: Biological Signalling Studies and Bioinspired Materials Research. It is a major boost to cutting-edge research in Freiburg: in the current Excellence Strategy competition, scientists at the University of Freiburg have been granted two Clusters of Excellence, CIBSS – Centre for Integrative Biological Signalling Studies, and livMatS – Living, Adaptive and Energy-autonomous Materials…

Press release - 10/12/2018

High distinction for stem cell researcher Andreas Trumpp

This year's State Research Prize of Baden-Württemberg awarded for outstanding achievements in applied research goes to Andreas Trumpp from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM). Theresia Bauer, State Minister of Science, Research and the Arts, presented the award, which carries a monetary prize of €100.000, at a festive ceremony on December 10, 2018.

Spindiag, a young medtech company in the German state of Baden-Württemberg, announced today the expanded financing of its first Series A. Based on a proprietary microfluidic technology first researched at the company’s mother institute Hahn-Schickard, Spindiag is developing a sustainable platform to diagnose infections and, as a first product, a rapid test for multidrug-resistant bacteria.

The latest articles, press releases and dossiers on diagnostics in Baden-Württemberg

Here you can download selected publications on the Baden-Württemberg healthcare industry.

Article - 20/01/2010

A new metabolic disease?

We take up amino acids with our food. They play a key role in almost all life processes in the human body. But what happens when the molecular machinery in the cells is no longer able to correctly process the amino acids? It was only about six years ago that Prof. Dr. Jörn Oliver Saß and his colleagues at the Freiburg University Medical Centre discovered a new metabolic disorder characterised by the defective degradation of a N-acetylated amino…

Noroviruses often might be the causative agents of Nausea vomiting diarrhoea fever. The Chemical and Veterinary Investigation Office in Stuttgart has now developed a method that enables the detection of these viruses on food.

Article - 14/02/2011

A molecule that enables local virus defence

Dr. Markus Mordstein has spent the last four years as a doctoral student at the University of Freiburg investigating the previously relatively unknown interferon lambda. He has been able to show that this molecule has similar protective functions to type I interferons and he has also found that it is far more selective in terms of the site where it exerts its effect.

Article - 15/07/2013

A horse in cow’s clothing

Control is good dual control even better. Blind trust in the food industry is not always the best idea. Dioxin EHEC and the horsemeat scandal show how vulnerable safety of the food chain is in a globalised world and also highlights the continuously changing challenges facing food inspectors. Food inspection aims to protect consumers from potential harm caused by food and against fraud committed by the industry.